Jeri Kim
Impact in
-
- Prostate Cancer Treatment and Research
- Prostate Cancer Diagnosis and Treatment
- Oncology top 2%
- Bone health and treatments
Papers in
-
- Prostate Cancer Treatment and Research 49
- Prostate Cancer Diagnosis and Treatment 19
- Oncology 30
- Cancer Immunotherapy and Biomarkers 11
- PARP inhibition in cancer therapy 7
- Co-authors
- Christopher J. Logothetis (40 shared papers)Patricia Troncoso (17 shared papers)Lance C. Pagliaro (10 shared papers)Randall E. Millikan (5 shared papers)Shi‐Ming Tu (11 shared papers)Ana M. Aparicio (8 shared papers)John W. Davis (23 shared papers)Danai Daliani (4 shared papers)
- Journals
- Journal of Clinical Oncology (20 papers)Clinical Genitourinary Cancer (5 papers)British Journal of Urology (4 papers)The Journal of Urology (4 papers)Clinical Cancer Research (4 papers)
- Partner nations
- United StatesSpainUnited Kingdom
In The Last Decade
Jeri Kim
99 papers receiving 3.3k citations
Jeri Kim's Hit Papers
Peers
Comparison fields: 5 of 116
- Pulmonary and Respiratory Medicine 1.2k
- Oncology 880
- Cancer Research 450
- Radiology, Nuclear Medicine and Imaging 420
- Molecular Biology 1.1k
Countries citing papers authored by Jeri Kim
This map shows the geographic impact of Jeri Kim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeri Kim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeri Kim more than expected).
Fields of papers citing papers by Jeri Kim
This network shows the impact of papers produced by Jeri Kim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeri Kim. The network helps show where Jeri Kim may publish in the future.
Co-authors
The 25 scholars most cited alongside Jeri Kim, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 102 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2004 | 372 | |
| 2 | Platinum-Based Chemotherapy for Variant Castrate-Resistant Prostate Cancer Hit paper breakdown → | 2013 | 315 |
| 3 | 2001 | 278 | |
| 4 | 2002 | 265 | |
| 5 | 2013 | 103 | |
| 6 | 2016 | 99 | |
| 7 | 2014 | 93 | |
| 8 | 2018 | 86 | |
| 9 | 2015 | 81 | |
| 10 | 2004 | 73 | |
| 11 | 2005 | 68 | |
| 12 | 2017 | 63 | |
| 13 | 2009 | 60 | |
| 14 | 2011 | 60 | |
| 15 | 2012 | 56 | |
| 16 | 2005 | 56 | |
| 17 | 2020 | 52 | |
| 18 | 2019 | 48 | |
| 19 | 2018 | 42 | |
| 20 | 2015 | 41 |
About Jeri Kim
Jeri Kim is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Molecular Biology, Radiology, Nuclear Medicine and Imaging and Cancer Research, having authored 102 papers that have together received 3.4k indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (49 papers), Prostate Cancer Diagnosis and Treatment (19 papers), Cancer Immunotherapy and Biomarkers (11 papers), Radiopharmaceutical Chemistry and Applications (10 papers), Cancer, Lipids, and Metabolism (9 papers), PARP inhibition in cancer therapy (7 papers), Estrogen and related hormone effects (5 papers) and Peroxisome Proliferator-Activated Receptors (4 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (1.2k citations), Oncology (880 citations), Cancer Research (450 citations), Radiology, Nuclear Medicine and Imaging (420 citations) and Molecular Biology (1.1k citations). Jeri Kim has collaborated with scholars based in United States, Spain and United Kingdom. Frequent co-authors include Christopher J. Logothetis, Patricia Troncoso, Lance C. Pagliaro, Randall E. Millikan, Shi‐Ming Tu, Ana M. Aparicio, John W. Davis, Danai Daliani, Wadih Arap and Christos N. Papandreou. Their work appears in journals such as Journal of Clinical Oncology, Clinical Genitourinary Cancer, British Journal of Urology, The Journal of Urology and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.